Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

(2012) Mehdi Hamadani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantation for Hematologic Malignancies

(2012) Dawn Sheppard et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria

(2012) Nicola Piccirillo et al.   TRANSFUSION AND APHERESIS SCIENCE

Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

(2011) A Olivieri et al.   BONE MARROW TRANSPLANTATION

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

(2009) Jin Seok Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CR represents an early index of potential long survival in multiple myeloma

(2009) M Wang et al.   BONE MARROW TRANSPLANTATION